October 16, 2005 -- With everyone worried about a possible bird flu pandemic, attention is once again focused on vaccines and vaccine makers. Although vaccine development is not generally considered a hot business, it is getting a lot of attention at the moment, and big pharma is spending billions to enter (or re-enter) the field. We think the vaccine makers are worth a look, so we see what is happening and who is doing it...
